Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants

M. Ziche, S. Donnini, L. Morbidelli, A. Parenti, G. Gasparini, F. Ledda

Research output: Contribution to journalArticlepeer-review

Abstract

The blocking of angiogenesis provides a novel therapeutic target to inhibit tumour spreading. In this study, we investigated the effect of linomide on angiogenesis induced in vivo by highly angiogenic breast carcinoma cells. The rabbit cornea was used to assess neovascular growth in the absence of a tumour mass. MCF-7 cells stably transfected with the cDNA encoding for vascular endothelial growth factor 121 (VEGF121) (V12 clone) were used to elicit a potent VEGF-dependent corneal angiogenesis. After tumour cell implant, albino rabbits received 100 mg kg-1 day-1 linomide for 5 consecutive days. Daily observation of neovascular progression indicated that linomide blocked angiogenesis. The antiangiogenic effect of linomide was apparent within 48 h from the beginning of the treatment and was both angiosuppressive and angiostatic. The block of neovascular growth lasted over 10 days from treatment suspension, and preformed vessels, which had regressed, remained dormant, suggesting the persistence of unfavourable conditions for capillary progression. Linomide (50-200 μg ml-1) was not cytotoxic in vitro on resting capillary endothelial cells but blocked endothelial cell replication induced by VEGF. Our data indicate that linomide can efficiently and persistently block VEGF-dependent angiogenesis in vivo in the absence of a growing tumour mass. These data suggest that linomide could be a chemopreventive drug in breast cancer patients and a valuable tool in clinical settings in which metastatic spreading occurs in the absence of a detectable tumour mass.

Original languageEnglish
Pages (from-to)1123-1129
Number of pages7
JournalBritish Journal of Cancer
Volume77
Issue number7
Publication statusPublished - Apr 1998

Keywords

  • Angiogenesis
  • Breast carcinoma
  • Endothelial cells
  • Linomide
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants'. Together they form a unique fingerprint.

Cite this